Rochelle Fuhrmann - Jun 1, 2022 Form 4 Insider Report for Histogen Inc. (HSTO)

Role
Director
Signature
/s/ Susan A. Knudson as attorney-in-fact for Rochelle Fuhrmann
Stock symbol
HSTO
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:34 PM
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +1K $0.00 1K Jun 1, 2022 Common Stock 1K $3.20 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 and the exercise price have been adjusted to reflect the Reverse Stock Split.
F2 This option was issued to the Reporting Person, a non-employee director of the Issuer, for her service as a director of the Issuer.
F3 The shares subject to this option become fully vested and exercisable on 6/1/2023, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.